Tonix Pharmaceuticals Hol... (TNXP)

AI Score

Unlock

15.53

-1.96 (-11.21%)

At close: Apr 04, 2025, 3:59 PM

15.70

1.09%

After-hours: Apr 04, 2025, 05:56 PM EDT

Tonix Pharmaceuticals Balance Sheet Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008
Cash & Equivalents	98.78M	24.95M	120.23M	178.66M	77.07M	11.25M	25.03M	25.5M	18.94M	19.18M	38.18M	8.2M	1.79M	41.12K	4.62K	12.61K	40.48K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	7.18M	23.84M	n/a	n/a	n/a	n/a	n/a	425.00	4.88K
Long-Term Investments	n/a	n/a	241K	240K	240K	100K	100K	89K	89K	189K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	951K	1.13M	143K	259K	245K	100K	100K	100K	100K	189K	-13.23B	60K	60.27K	256.34K	n/a	n/a	n/a
Receivables	8.08M	4.59M	n/a	7.73M	7.63M	n/a	n/a	n/a	n/a	2.83M	n/a	n/a	n/a	n/a	n/a	n/a	552.00
Inventory	8.41M	14.15M	-8.04M	-7.73M	-7.63M	-1.01M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	3.73M	2.43M	1.23M	1.18M	1.66M	400K	1.02M	n/a	n/a	n/a	852K	429K	n/a	n/a	n/a	n/a	n/a
Total Current Assets	119M	47.77M	130.78M	189.05M	87.99M	13.95M	26.06M	26.44M	27.14M	46.36M	39.04M	8.63M	2.01M	143.55K	4.62K	13.03K	45.91K
Property-Plant & Equipment	42.82M	94.85M	94.53M	51.47M	9.83M	390K	43K	91K	150K	350K	328K	45K	46.89K	25.55K	n/a	n/a	n/a
Goodwill & Intangibles	120K	10.71M	120K	120K	120K	120K	120K	120K	120K	120K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	43.89M	106.69M	94.91M	51.85M	10.19M	610K	263K	311K	370K	659K	506K	105K	107.16K	281.89K	n/a	n/a	n/a
Total Assets	162.89M	154.46M	225.69M	240.9M	98.18M	14.56M	26.32M	26.75M	27.51M	47.02M	39.54M	8.74M	2.12M	425.45K	4.62K	13.03K	45.91K
Account Payables	4.55M	3.78M	8.07M	13.28M	4.6M	3.07M	1.4M	1.3M	872K	3.05M	1.49M	765K	825K	695.2K	317.75K	988.00	n/a
Deferred Revenue	n/a	2.98M	3.27M	2.83M	2.17M	704K	475K	519K	504K	2.25M	n/a	n/a	n/a	48.53K	n/a	n/a	n/a
Short-Term Debt	3.09M	2.35M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	280K	n/a	150K	n/a	n/a	n/a
Other Current Liabilities	6.31M	5.14M	2.76M	2.25M	452K	319K	n/a	n/a	n/a	n/a	1.47M	n/a	n/a	31.54K	n/a	n/a	3K
Total Current Liabilities	18.31M	18.88M	18.18M	21.72M	9.82M	5.13M	2.65M	2.13M	2.12M	6.65M	3.38M	2.21M	1.14M	925.28K	10.3K	988.00	3K
Long-Term Debt	5.03M	6.56M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.93M	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	22.86M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	68K	13K	n/a	29.08K	n/a	n/a	n/a
Total Long-Term Liabilities	5.03M	30.05M	328K	467K	716K	6K	n/a	12K	33K	106K	68K	13K	19.71K	1.95M	n/a	n/a	n/a
Total Liabilities	23.33M	48.93M	18.51M	22.18M	10.54M	5.14M	2.65M	2.14M	2.15M	6.76M	3.45M	2.22M	1.16M	2.88M	10.3K	988.00	3K
Total Debt	8.12M	9.81M	760K	956K	1.31M	358K	n/a	n/a	n/a	n/a	n/a	280K	n/a	2.08M	n/a	n/a	n/a
Common Stock	4K	59K	76K	496K	206K	9K	3K	8K	4K	19K	11K	6K	43.18K	27.07K	5.5K	5.5K	5.5K
Retained Earnings	-730.69M	-600.66M	-470.04M	-359.82M	-267.53M	-217.07M	-188.45M	-162.36M	-141.24M	-102.4M	-54.34M	-26.73M	-15.84M	-6.39M	-70.68K	-52.96K	-22.09K
Comprehensive Income	-255K	-232K	-167K	-92K	-62K	-46K	-41K	-12K	-7K	-17K	2K	-1K	-31.64K	-17.31K	n/a	n/a	n/a
Shareholders Equity	139.56M	105.53M	207.18M	218.72M	87.65M	9.42M	23.66M	24.62M	25.36M	40.26M	36.09M	6.51M	958.71K	-2.45M	-5.68K	12.04K	42.91K
Total Investments	n/a	900K	241K	240K	240K	100K	100K	89K	7.18M	23.84M	n/a	n/a	n/a	n/a	n/a	425.00	4.88K